Labcorp Holdings annual shareholders’ equity
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Labcorp Holdings Shareholders’ Equity Growth & History (LH)
Labcorp Holdings's shareholders’ equity was $8.62B for fiscal 2025.
View full Labcorp Holdings company overviewLabcorp Holdings annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $8.62B | $567.6M | +7.05% |
| 2024 | 2024-12-31 | $8.05B | $177.2M | +2.25% |
| 2023 | 2023-12-31 | $7.88B | −$2.22B | −22.00% |
| 2022 | 2022-12-31 | $10.10B | −$176.8M | −1.72% |
| 2021 | 2021-12-31 | $10.27B | $836.8M | +8.87% |
| 2020 | 2020-12-31 | $9.44B | $1.79B | +23.45% |
| 2019 | 2019-12-31 | $7.64B | $595.6M | +8.45% |
| 2018 | 2018-12-31 | $7.05B | $244.2M | +3.59% |
| 2017 | 2017-12-31 | $6.80B | $1.29B | +23.30% |
| 2016 | 2016-12-31 | $5.52B | $573.1M | +11.59% |
| 2015 | 2015-12-31 | $4.95B | $2.12B | +75.33% |
| 2014 | 2014-12-31 | $2.82B | $329.2M | +13.21% |
| 2013 | 2013-12-31 | $2.49B | −$2.45B | −49.62% |
| 2012 | 2012-12-31 | $4.95B | $2.44B | +97.53% |
| 2011 | 2011-12-31 | $2.50B | $37.2M | +1.51% |
| 2010 | 2010-12-31 | $2.47B | $360.2M | +17.10% |
| 2009 | 2009-12-31 | $2.11B | $417.8M | +24.75% |
| 2008 | 2008-12-31 | $1.69B | −$37.0M | −2.14% |
| 2007 | 2007-12-31 | $1.73B | — | — |
Labcorp Holdings quarterly shareholders’ equity
Q4.08
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $8.61B | $134.1M | +1.58% |
| Q1 2026 | 2026-03-31 | $8.73B | $421.2M | +5.07% |
| Q4 2025 | 2025-12-31 | $8.62B | $567.6M | +7.05% |
| Q3 2025 | 2025-09-30 | $8.70B | $526.7M | +6.45% |
| Q2 2025 | 2025-06-30 | $8.47B | $466.9M | +5.83% |
| Q1 2025 | 2025-03-31 | $8.31B | $347.8M | +4.37% |
| Q4 2024 | 2024-12-31 | $8.05B | $177.2M | +2.25% |
| Q3 2024 | 2024-09-30 | $8.17B | $297.1M | +3.77% |
| Q2 2024 | 2024-06-30 | $8.01B | −$779.2M | −8.87% |
| Q1 2024 | 2024-03-31 | $7.96B | −$825.4M | −9.40% |
| Q4 2023 | 2023-12-31 | $7.88B | −$2.22B | −22.00% |
| Q3 2023 | 2023-09-30 | $7.87B | −$2.22B | −21.99% |
| Q2 2023 | 2023-06-30 | $8.79B | −$1.62B | −15.53% |
| Q1 2023 | 2023-03-31 | $8.79B | −$1.94B | −18.06% |
| Q4 2022 | 2022-12-31 | $10.10B | −$176.8M | −1.72% |
| Q3 2022 | 2022-09-30 | $10.09B | −$509.2M | −4.80% |
| Q2 2022 | 2022-06-30 | $10.40B | $78.7M | +0.76% |
| Q1 2022 | 2022-03-31 | $10.72B | $699.6M | +6.98% |
| Q4 2021 | 2021-12-31 | $10.27B | $836.8M | +8.87% |
| Q3 2021 | 2021-09-30 | $10.60B | $2.36B | +28.67% |
| Q2 2021 | 2021-06-30 | $10.32B | $2.97B | +40.38% |
| Q1 2021 | 2021-03-31 | $10.02B | $3.00B | +42.75% |
| Q4 2020 | 2020-12-31 | $9.44B | $1.79B | +23.45% |
| Q3 2020 | 2020-09-30 | $8.24B | $1.01B | +13.94% |
| Q2 2020 | 2020-06-30 | $7.35B | $208.3M | +2.92% |
| Q1 2020 | 2020-03-31 | $7.02B | −$91.2M | −1.28% |
| Q4 2019 | 2019-12-31 | $7.64B | $595.6M | +8.45% |
| Q3 2019 | 2019-09-30 | $7.23B | −$17.0M | −0.23% |
| Q2 2019 | 2019-06-30 | $7.14B | $106.7M | +1.52% |
| Q1 2019 | 2019-03-31 | $7.11B | $127.3M | +1.82% |
| Q4 2018 | 2018-12-31 | $7.05B | $244.2M | +3.59% |
| Q3 2018 | 2018-09-30 | $7.25B | $1.13B | +18.46% |
| Q2 2018 | 2018-06-30 | $7.04B | $1.16B | +19.75% |
| Q1 2018 | 2018-03-31 | $6.98B | $1.33B | +23.54% |
| Q4 2017 | 2017-12-31 | $6.80B | $1.29B | +23.30% |
| Q3 2017 | 2017-09-30 | $6.12B | $514.1M | +9.17% |
| Q2 2017 | 2017-06-30 | $5.88B | $563.8M | +10.61% |
| Q1 2017 | 2017-03-31 | $5.65B | $486.7M | +9.42% |
| Q4 2016 | 2016-12-31 | $5.52B | $573.1M | +11.59% |
| Q3 2016 | 2016-09-30 | $5.60B | $797.3M | +16.59% |
| Q2 2016 | 2016-06-30 | $5.31B | $546.8M | +11.47% |
| Q1 2016 | 2016-03-31 | $5.17B | $768.7M | +17.48% |
| Q4 2015 | 2015-12-31 | $4.95B | $2.12B | +75.33% |
| Q3 2015 | 2015-09-30 | $4.81B | $2.04B | +73.50% |
| Q2 2015 | 2015-06-30 | $4.77B | $2.11B | +79.42% |
| Q1 2015 | 2015-03-31 | $4.40B | $1.90B | +75.82% |
| Q4 2014 | 2014-12-31 | $2.82B | $329.2M | +13.21% |
| Q3 2014 | 2014-09-30 | $2.77B | $205.2M | +8.00% |
| Q2 2014 | 2014-06-30 | $2.66B | −$7.0M | −0.26% |
| Q1 2014 | 2014-03-31 | $2.50B | −$277.0M | −9.97% |
| Q4 2013 | 2013-12-31 | $2.49B | −$2.45B | −49.62% |
| Q3 2013 | 2013-09-30 | $2.57B | −$151.1M | −5.56% |
| Q2 2013 | 2013-06-30 | $2.66B | $31.6M | +1.20% |
| Q1 2013 | 2013-03-31 | $2.78B | $180.7M | +6.96% |
| Q4 2012 | 2012-12-31 | $4.95B | $2.44B | +97.53% |
| Q3 2012 | 2012-09-30 | $2.72B | $173.4M | +6.82% |
| Q2 2012 | 2012-06-30 | $2.63B | $52.0M | +2.02% |
| Q1 2012 | 2012-03-31 | $2.60B | $197.2M | +8.22% |
| Q4 2011 | 2011-12-31 | $2.50B | $37.2M | +1.51% |
| Q3 2011 | 2011-09-30 | $2.54B | $273.1M | +12.03% |
| Q2 2011 | 2011-06-30 | $2.58B | $370.8M | +16.79% |
| Q1 2011 | 2011-03-31 | $2.40B | $242.0M | +11.21% |
| Q4 2010 | 2010-12-31 | $2.47B | $360.2M | +17.10% |
| Q3 2010 | 2010-09-30 | $2.27B | $241.4M | +11.90% |
| Q2 2010 | 2010-06-30 | $2.21B | $199.7M | +9.94% |
| Q1 2010 | 2010-03-31 | $2.16B | — | — |
| Q4 2009 | 2009-12-31 | $2.11B | $417.8M | +24.75% |
| Q3 2009 | 2009-09-30 | $2.03B | — | — |
| Q2 2009 | 2009-06-30 | $2.01B | — | — |
| Q4 2008 | 2008-12-31 | $1.69B | — | — |
Labcorp Holdings shareholders’ equity trends
Over the last five fiscal years, Labcorp Holdings's shareholders’ equity decreased from $9.44B to $8.62B, a change of −$816.8M. The latest reported quarter, Q2 2026, shows $8.61B.
About the metric
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
Calculation and source
SEC-reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company SEC filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Labcorp Holdings source filings ↗Community posts
Labcorp sets new medium-term growth targets and reaffirms its annual outlook
Labcorp ($LH) set medium-term targets for annual revenue growth of 5–8% and adjusted earnings-per-share growth of 8.5–11.5% through 2029. The company also reaffirmed its existing 2026 guidance. The new framework describes the performance ma ...
Labcorp acquires MLM Medical Labs to expand clinical-trial services
Labcorp ($LH) acquired MLM Medical Labs, adding central and specialty laboratory operations in the United States, Germany and South Africa. The company said the purchase expands its biomarker-testing capabilities and improves its ability to ...